[Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate].
The anti-hypertensive action of 2,6-dichlorobenzylideneaminoguanidine acetate (BR 750) is described. Inter-patient comparison pointed out its excellent tolerance, together with an anti-hypertensive activity at least equal to that of alpha-methyldopa.
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006143:Guanabenz / Q000627:therapeutic use*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged
D000959:Antihypertensive Agents; D006146:Guanidines; D008750:Methyldopa; D006143:Guanabenz
Sull'attività anti-ipertensiva di una nuova molecola, il 2,6-dicloro-benziliden aminoguanidina acetato